2018
DOI: 10.1101/304329
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Frequencies of circulating Th1-biased T follicular helper cells in acute HIV-1 infection correlate with the development of HIV-specific antibody responses and lower set point viral load

Abstract: Word count:243) 24Despite decades of focused research, the field has yet to develop a prophylactic vaccine. In the 25 RV144 vaccine trial, non-neutralizing antibody responses were identified as a correlate for 26 prevention of HIV acquisition. However, factors that predict the development of such antibodies 27 are not fully elucidated. We sought to define the contribution of circulating T follicular helper 28 (cTfh) cell subsets to the development of non-neutralizing antibodies in HIV-1 clade C infection. 29St… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 51 publications
0
8
0
Order By: Relevance
“…When we quantified peripheral blood CD4 + CXCR5 + PD‐1 + T FH by flow cytometry (gating strategy Figure S3), we did not observe significant differences between the 2 groups (Figure 4A). We also did not observe significant differences in the frequencies of CD4 + CXCR5 + PD‐1 + CCR6 − CXCR3 + T FH1 cells (implicated as crucial in antiviral antibody responses 15 ), CD4 + CXCR5 + PD‐1 + CCR6 − CXCR3 − T FH2 cells (important for maturation of B cells into IgG4‐secreting cells 16 ), nor in the CD4 + CXCR5 + PD‐1 + CCR6 + CXCR3 − T FH17 cells 17 between groups (Figure 4B‐D).…”
Section: Resultsmentioning
confidence: 45%
“…When we quantified peripheral blood CD4 + CXCR5 + PD‐1 + T FH by flow cytometry (gating strategy Figure S3), we did not observe significant differences between the 2 groups (Figure 4A). We also did not observe significant differences in the frequencies of CD4 + CXCR5 + PD‐1 + CCR6 − CXCR3 + T FH1 cells (implicated as crucial in antiviral antibody responses 15 ), CD4 + CXCR5 + PD‐1 + CCR6 − CXCR3 − T FH2 cells (important for maturation of B cells into IgG4‐secreting cells 16 ), nor in the CD4 + CXCR5 + PD‐1 + CCR6 + CXCR3 − T FH17 cells 17 between groups (Figure 4B‐D).…”
Section: Resultsmentioning
confidence: 45%
“…Several studies have demonstrated that cT FH cells play an important role in HIV-specific humoral immunity ( 15 , 20 , 22 , 69 ). We next investigated whether immunization elicited cT FH responses in the blood of female rhesus macaques and whether vaccine-induced cT FH responses contributed to anti-HIV humoral immunity.…”
Section: Resultsmentioning
confidence: 99%
“…In humans, circulating CCR7 + PD1 + CXCR5 + CD4 + T cells were shown to be antigen-experienced cT FH cells able to return to nondraining secondary lymphoid organs to support rapid GC formation upon antigen reencounter ( 74 ). Likewise, generation of CCR7 + PD-1 + cT FH cells, central memory cells by virtue of CCR7 expression ( 20 , 69 ), may also play a role in faster GC reactions following antigen re-exposure in immunized rhesus macaques.…”
Section: Discussionmentioning
confidence: 99%
“…Further highlighting the importance of specific Th2-cTfh targeting in vaccine optimization, the co-administration of viral vectored vaccines with RTS,S skewed the cTfh cell response toward Th1-cTfh cell activation, to the detriment of functional antibody induction and vaccine efficacy. 49 In contrast, multiple studies have shown that Th1-Tfh cells are associated with antibody induction to viral infections and vaccinations, including SARS-CoV-2, 16 , 17 , 18 , 19 highlighting that distinct vaccine approaches may be required for malaria vaccines compared to viral pathogens.…”
Section: Discussionmentioning
confidence: 99%
“…For example, Th2-cTfh cells have been associated with the acquisition of broadly neutralizing antibodies against HIV, 10 while Th1-cTfh cells are linked to the induction of antibodies following viral infection and vaccination, including influenza, HIV, and severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). 16 , 17 , 18 , 19 …”
Section: Introductionmentioning
confidence: 99%